Clinical trial
Insulin Resistance Intervention After Stroke Trial
NCT00091949
Study timeline
Study start (unknown)2005-02-01Date precision: month
Registry last updated2020-04-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Strokeverified · MONDO: stroke disorder
Diabetesverified · MONDO: diabetes mellitus
Interventions
pioglitazoneDRUG · verified · RxNorm: pioglitazone
placeboDRUG
Sponsors & collaborators
Yale Universitylead sponsor
Takeda Pharmaceuticals North America, Inc.collaborator
Mapped research locations
BostonMassachusetts, United States4ChicagoIllinois, United States3St LouisMissouri, United States3ClevelandOhio, United States3HaifaIsrael3New YorkNew York, United States2Los AngelesCalifornia, United States2PhiladelphiaPennsylvania, United States2DallasTexas, United States2BaltimoreMaryland, United States2LondonUnited Kingdom2PittsburghPennsylvania, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00091949 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.